CN103408551A - 阿立塞替的制备方法 - Google Patents
阿立塞替的制备方法 Download PDFInfo
- Publication number
- CN103408551A CN103408551A CN2013103161513A CN201310316151A CN103408551A CN 103408551 A CN103408551 A CN 103408551A CN 2013103161513 A CN2013103161513 A CN 2013103161513A CN 201310316151 A CN201310316151 A CN 201310316151A CN 103408551 A CN103408551 A CN 103408551A
- Authority
- CN
- China
- Prior art keywords
- lisai
- preparation
- chloro
- fluoro
- replaces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310316151.3A CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310316151.3A CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103408551A true CN103408551A (zh) | 2013-11-27 |
CN103408551B CN103408551B (zh) | 2015-08-05 |
Family
ID=49601607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310316151.3A Active CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103408551B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103788020A (zh) * | 2014-01-22 | 2014-05-14 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014603A (zh) * | 2004-05-14 | 2007-08-08 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CN102770024A (zh) * | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
WO2012167247A1 (en) * | 2011-06-03 | 2012-12-06 | Millennium Pharmaceuticals, Inc. | Combination of mek inhibitors and selective inhibitors of aurora a kinase |
-
2013
- 2013-07-25 CN CN201310316151.3A patent/CN103408551B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014603A (zh) * | 2004-05-14 | 2007-08-08 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CN102770024A (zh) * | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
WO2012167247A1 (en) * | 2011-06-03 | 2012-12-06 | Millennium Pharmaceuticals, Inc. | Combination of mek inhibitors and selective inhibitors of aurora a kinase |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103788020A (zh) * | 2014-01-22 | 2014-05-14 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
CN103788020B (zh) * | 2014-01-22 | 2015-11-04 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103408551B (zh) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104496983B (zh) | 一种帕博西尼的制备方法 | |
CN103626774B (zh) | 伊鲁替尼的制备方法 | |
CN104447743B (zh) | 帕博西尼的制备方法 | |
CN103254179B (zh) | 阿伐那非的制备方法 | |
CN107936029B (zh) | 一种合成瑞博西尼的方法 | |
EP3741758A1 (en) | Bromodomain inhibitor compound and use thereof | |
CN104262257A (zh) | 一种吡唑衍生物的制备方法 | |
CN112679420A (zh) | 一种2,5-二溴吡啶的制备方法 | |
CN103172636B (zh) | 吡啶并喹唑啉酮类化合物及其制备方法 | |
CN103254180B (zh) | 一种阿伐那非的制备方法 | |
CN103288808B (zh) | 一种阿法替尼的制备方法 | |
CN105085484B (zh) | 一种富马酸沃诺拉赞的制备方法 | |
CN105198821B (zh) | 洛昔替尼的制备方法 | |
CN103288758B (zh) | 一种达克米替尼的制备方法 | |
CN104447620B (zh) | 1-[3-[3-(4-氯苯基)丙氧基]丙基]-哌啶盐酸盐的制备方法 | |
JP2013216655A (ja) | ブロナンセリンの改善された調製方法 | |
CN104478898A (zh) | 依维莫司及其中间体的制备方法 | |
CN103408551B (zh) | 阿立塞替的制备方法 | |
CN103304567B (zh) | 一种替卡格雷的制备方法 | |
CN104829590A (zh) | 一种纯化曲格列汀的方法 | |
CN110016023B (zh) | 一种帕博西尼的简便制备方法 | |
CN105061467A (zh) | 一种帕克替尼的制备方法 | |
CN105985317A (zh) | 一种色瑞替尼的制备方法及其中间体 | |
US9688685B2 (en) | Method for preparing volasertib and intermediate thereof | |
CN105153169A (zh) | 一种盐酸依匹斯汀的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200513 Address after: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee after: Nanjing Zhiwu Intelligent Technology Co.,Ltd. Address before: 215000 Jiangsu Province, Suzhou City Industrial Park Commercial Plaza Building 1 room 1305 Lianfeng Co-patentee before: Xu Xuenong Patentee before: SUZHOU MIRACPHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201204 Address after: 215600 building 145, building A, emerging industry incubation center, Zhangjiagang Free Trade Zone, Suzhou, Jiangsu Patentee after: SUZHOU RUNTONG PATENT OPERATION Co.,Ltd. Address before: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee before: Nanjing Zhiwu Intelligent Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230915 Address after: No. 1 Minsheng Road, Daishi Town, Qianfeng District, Guang'an City, Sichuan Province, 638500 Patentee after: Wei Chunjiang Address before: 215600 room 145, A building, new industry incubation center, Zhangjiagang Free Trade Zone, Suzhou, Jiangsu Patentee before: SUZHOU RUNTONG PATENT OPERATION Co.,Ltd. |
|
TR01 | Transfer of patent right |